Form D — SightStream Biotherapeutics, Inc.
0001932386-25-000003 · filed Oct 16, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,791,165
- Reported amount sold
- $1,791,165
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SightStream Biotherapeutics, Inc.
- CIK
- 1932386
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 55 WEST STREET, SUITE 201
WALPOLE, Massachusetts 02081 - Phone
- 617-388-2635
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jason Werner · Executive OfficerWalpole, Massachusetts Find on LinkedIn ↗
-
Reza Dana · DirectorWalpole, Massachusetts Find on LinkedIn ↗
-
Samuel Wu · DirectorWalpole, Massachusetts Find on LinkedIn ↗
-
Wenkai Xiang · DirectorWalpole, Massachusetts Find on LinkedIn ↗
-
David Neafus · Executive OfficerWalpole, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗